Daniela Marti

Daniela Marti


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
Daniel Florin PancuDaniel Florin Pancu
Daniel Florin Pancu
A(Alexandra Denisa Semenescu (Scurtu)
Alexandra Denisa Semenescu (Scurtu)
IMIoana Macasoi
Ioana Macasoi
DMDaniela Marti
Daniela Marti
MMMarius Mioc
Marius Mioc
CRISTINA ADRIANA DEHELEANCRISTINA ADRIANA DEHELEAN
CRISTINA ADRIANA DEHELEAN
Antibiotics are considered as a cornerstone of modern medicine and their discovery offers the resolution to the infectious diseases problem. However, the excessive use of antibiotics worldwide has generated a critical public health issue and the bacterial resistance correlated with antibiotics inefficiency is still unsolved. Finding novel therapeutic approaches to overcome bacterial resistance is imperative, and natural compounds with antibacterial effects could be considered a promising option. The role played by antibiotics in tumorigenesis and their interrelation with the microbiota are still debatable and are far from being elucidated. Thus, the present manuscript offers a global perspective on antibiotics in terms of evolution from a historical perspective with an emphasis on the main classes of antibiotics and their adverse effects. It also highlights the connection between antibiotics and microbiota, focusing on the dual role played by antibiotics in tumorigenesis. In addition, using the natural compounds with antibacterial properties as potential alternatives for the classical antibiotic therapy is discussed.

1 January 2018 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
Iulia Andreea PinzaruIulia Andreea Pinzaru
Iulia Andreea Pinzaru
DCDorina Coricovac
Dorina Coricovac
CRISTINA ADRIANA DEHELEANCRISTINA ADRIANA DEHELEAN
CRISTINA ADRIANA DEHELEAN
Elena Alina MoacaElena Alina Moaca
Elena Alina Moaca
MMMarius Mioc
Marius Mioc
Codruta SoicaCodruta Soica
Codruta Soica

8 August 2023 in Diseases
Verified
Journal Article
Open access
PDF file
LMLarisa Mihaela Marusca
Larisa Mihaela Marusca
GRGowry Reddy
Gowry Reddy
MBMihaela Blaj
Mihaela Blaj
RPreshmanth prathipati
reshmanth prathipati
OROvidiu Rosca
Ovidiu Rosca
AMAdelina Mavrea
Adelina Mavrea
Childhood respiratory tract infections (RTIs) pose a significant health burden, especially in children under six years old. The main objective of this systematic review was to assess the effectiveness of vitamin D supplementation in the prevention of RTI in this population while also exploring potential effect modifiers such as age, baseline vitamin D status, and type of respiratory infection. A systematic review of the literature published up to February 2023 was conducted according to PRISMA guidelines, searching PubMed, Web of Science, Cochrane, and Scopus databases. Eight studies met the inclusion criteria, which investigated the association between vitamin D supplementation and respiratory infections in children between zero and five years old. The included studies were conducted between 2012 and 2021, encompassing a total of 2189 children from five randomized trials, two case-control studies, and one prospective cohort study. The relationship between vitamin D supplementation and the prevention of childhood RTI was not consistently observed across all included studies. Pooled results demonstrated varied effects of vitamin D supplementation on respiratory infection incidence, severity, and symptoms. Three studies reported statistically significant associations between low vitamin D levels and respiratory infections (OR = 4.90, OR = 6.97), while one study found that children who received vitamin D supplementation of 800 UI/day for 3 months during the cold season had fewer episodes of respiratory symptoms (RR = 0.55) and recovered more quickly from acute RTI. Lastly, according to one study, vitamin D intake < 80 IU/kg/day was significantly associated with the risk of acquiring pneumonia (OR 7.9) but not bronchiolitis. The remaining five studies found no statistically significant differences in infection rates or severity (p-value > 0.050). The available evidence on the effectiveness of vitamin D supplementation for preventing and treating respiratory infections in children under six years old is limited, with only a few favorable effects being reported. In some cases, a dose of 80 UI/kg/day was found to provide significant protection for acute respiratory infections, although in the major trials the only benefit was a quicker recovery and fewer respiratory symptoms, with no impact on incidence and severity of respiratory infections. Nevertheless, the study protocol, the supplementation dose, and duration of supplementation had significant variations between studies, leading to inconclusive findings.

2 November 2022 in Life
Verified
Journal Article
Open access
PDF file
AMAlin Gabriel Mihu
Alin Gabriel Mihu
MLMaria Alina Lupu
Maria Alina Lupu
ANAlexandru Nesiu
Alexandru Nesiu
DMDaniela Marti
Daniela Marti
Tudor Rares OlariuTudor Rares Olariu
Tudor Rares Olariu
Toxoplasma gondii, a zoonotic protozoan parasite, has the capacity to infect the fetus if the pregnant woman primarily acquires the infection during pregnancy. We evaluated the prevalence of T. gondii IgG, IgM and IgA antibodies in women of reproductive age residing in Western Romania. We also assessed the value of adding a T. gondii IgA test to the serologic panel for the diagnosis of toxoplasmosis, including the detection of a recently acquired infection. Serologic testing to demonstrate the presence of T. gondii IgG antibodies was conducted in 1317 females aged 15–45 years. T. gondii IgM and IgA antibody tests were performed in those with detectable IgG antibodies and IgG avidity test was performed if IgM and/or IgA screening test results were positive. T. gondii IgG were detected in 607 (46.09%; 95%CI: 43.41–48.79) of 1317 study participants and IgG seroprevalence tended to increase with age from 35.44% (95%CI: 29.89–41.30) in age group 15–24 years to 62.85% (95%CI: 56.57–68.82) in age group 35–45 years, showing a significant age-associated increase (p < 0.001). Of the 607 persons with detectable T. gondii IgG antibodies, T. gondii IgM antibodies were demonstrated in 8.90% (95%CI: 6.88–11.43), T. gondii IgA in 1.65% (95%CI: 0.90–3.01) and both T. gondii IgM and IgA in 0.99% (95%CI: 0.45–2.14). The prevalence of IgA antibodies tended to decrease with increasing avidity, from 75% (95%CI: 19.41–99.37) in samples with low avidity to 11.76% (95%CI: 4.44–23.87) in those with high avidity (p = 0.01). Of the study participants who were positive for both T. gondii IgM and IgA antibodies, 66.67% had low or equivocal IgG avidity test results compared to 6.25% who tested positive for IgM, were negative for IgA and in whom low or equivocal IgG avidity test results were noted (p = 0.001). This study indicates that in Western Romania, T. gondii IgG seroprevalence is high in females of reproductive age and T. gondii IgA antibodies may be rarely detected during a serologic screening. However, in individuals with demonstrable T. gondii IgG and IgM antibodies, testing for T. gondii IgA may improve the rate for the detection of a recently acquired toxoplasmosis.

19 June 2019
Verified
Book Chapter
Open access
PDF file
ASAdina-Elena Segneanu
Adina-Elena Segneanu
CCClaudiu Cepan
Claudiu Cepan
IOAN GROZESCUIOAN GROZESCU
IOAN GROZESCU
FCFlorentina Cziple
Florentina Cziple
SOSorin Olariu
Sorin Olariu
DMDaniela Marti
Daniela Marti
Romanian traditional medicine has an extremely old history. The Dacian knowledge of the curative properties of medicinal plants was documented by Herodotus, Hippocrates, Galen, and Dioscorides. It must be emphasized that modern chemical screening has confirmed the therapeutic properties of the medicinal plants used by the Dacians. More interesting is that Dacians used many of these herbs for different dishes. Practically, for Dacians, food was medicine. Recent research on some Romanian medicinal plants has highlighted their pharmacognostical importance. It is known that currently, the importance and dynamics of the research on medicinal plants in the area of drug discovery continues to increase worldwide. The main reason is not only the high efficiency of secondary metabolites in case of serious diseases (cancer, viral infections, malaria, etc.) but also the minimization of the side effects of the synthetic drugs.

30 August 2023 in Life
Verified
Journal Article
Open access
PDF file
OMOvidiu Mușat Mușat
Ovidiu Mușat Mușat
VSVirgiliu-Bogdan Sorop
Virgiliu-Bogdan Sorop
ȘMȘorop Ioana Mădălina
Șorop Ioana Mădălina
VLViorica Lazar
Viorica Lazar
DMDaniela Marti
Daniela Marti
MDMircea Mihai Diaconu
Mircea Mihai Diaconu
COVID-19 has significantly impacted the whole world, and Romania was no exception. Biomarkers play a crucial role in understanding and managing the disease. However, research regarding laboratory analyses for patients with COVID-19 is fairly limited. For detection, PCR testing is still considered the golden standard, while antibodies are still useful for monitoring both patients and their vaccination status. In our country, biomarkers such as CRP, LDH, transaminases, cardiac, and iron markers have been used to assess the status of patients and even predict illness outcome. CRP, IL-6, LDH, FER, fibrinogen, creatinine, and vitamin D levels have been associated with increased severity, risk of ICU admission, and death. Cardiac markers and D-dimers are also good predictors, but their role seems more important in patients with complications. HDL cholesterol and BUN levels were also suggested as potential biomarkers. Hematological issues in SARS-CoV-2 infections include neutrophilia, lymphopenia and their ratio, while PCT, which is a marker of bacterial infections, is better to be used in patients with co- or supra-infections. The current research is a narrative review that focuses on the laboratory results of Romanian COVID-19 patients. The goal of this article is to provide an update on the research on biomarkers and other laboratory tests conducted inside the borders of Romania and identify gaps in this regard. Secondly, options for further research are discussed and encouraged.